The FPAA believes that decisions about contraception should be made in conjunction with a health care professional and that everyone should have access to accurate and unbiased information to enable appropriate informed contraceptive choice.
LARCs (Long-Acting Reversible Contraception) including the levonorgestrel IUD (Mirena) and the subdermal implant (Implanon NXT) are the most effective reversible methods of contraception available. They have the additional advantage of being long lasting, convenient to use and generally well regarded by most users. LARC method failure rates rival that of tubal sterilization at <1% and unintended pregnancy rates are lower than those reported for contraceptive pill users. Like all progestogen only contraceptive methods, LARCs may result in a change of bleeding pattern which may include no bleeding, frequent or prolonged bleeding. The hormonal IUD provides highly effective a treatment for Heavy Menstrual Bleeding which can otherwise result in iron deficiency and anaemia.
Pelvic Inflammatory Disease (PID) is a known, uncommon side effect of IUD insertion but occurs in less than 1 in 300 people. The risk of PID is only increased for the first 3 weeks after insertion, after which it returns to the previous background risk. The background risk of PID in the Australian population is predominantly driven by sexually transmitted infection rates, particularly Chlamydia. Users of IUDs are encouraged to return at any sign of infection and when treated promptly with antibiotics are unlikely to experience any long term complications.
Subscribe to eNews
A boost for sexual health at True
Enhancing LGBTIQ+ affirming practice in clinical settings
For over 40 years, True has been one of the most respected providers of sexuality and relationship education in Australia. True is renowned for its expert clinical services, education and training and its innovative approach to child safety.